IS:TORNTPHARM Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also offers contract manufacturing services. It has collaboration agreements with Cipla Limited, Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Limited, and Sun Pharmaceutical Industries Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in an outpatient setting. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

3,191.00 INR
As of 01/17/2022

Security Information
Category1:  Global Equity
Category2:  Comon stocks
Category3:  Emerging markets
GICS sector:  Health Care
Index country:  India
Country of incorporation:  India
IPO date:  11/03/1994
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   540,532,113,408 INR
Current dividend yield:   0.94%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy